Abstract:Introductionp53 plays important roles in regulating the metabolic reprogramming of cancer, such as aerobic glycolysis. Oroxylin A is a natural active flavonoid with strong anticancer effects both in vitro and in vivo.Methodswt-p53 (MCF-7 and HCT116 cells) cancer cells and p53-null H1299 cancer cells were used. The glucose uptake and lactate production were analyzed using Lactic Acid production Detection kit and the Amplex Red Glucose Assay Kit. Then, the protein levels and RNA levels of p53, mouse double minute 2 (MDM2), and p53-targeted glycolytic enzymes were quantified using Western blotting and quantitative polymerase chain reaction (PCR), respectively. Immunoprecipitation were performed to assess the binding between p53, MDM2, and sirtuin-3 (SIRT3), and the deacetylation of phosphatase and tensin homolog (PTEN). Reporter assays were performed to assess the transcriptional activity of PTEN. In vivo, effects of oroxylin A was investigated in nude mice xenograft tumor-inoculated MCF-7 or HCT116 cells.ResultsHere, we analyzed the underlying mechanisms that oroxylin A regulated p53 level and glycolytic metabolism in wt-p53 cancer cells, and found that oroxylin A inhibited glycolysis through upregulating p53 level. Oroxylin A did not directly affect the transcription of wt-p53, but suppressed the MDM2-mediated degradation of p53 via downregulating MDM2 transcription in wt-p53 cancer cells. In further studies, we found that oroxylin A induced a reduction in MDM2 transcription by promoting the lipid phosphatase activity of phosphatase and tensin homolog, which was upregulated via sirtuin3-mediated deacetylation. In vivo, oroxylin A inhibited the tumor growth of nude mice-inoculated MCF-7 or HCT116 cells. The expression of MDM2 protein in tumor tissue was downregulated by oroxylin A as well.ConclusionsThese results provide a p53-independent mechanism of MDM2 transcription and reveal the potential of oroxylin A on glycolytic regulation in both wt-p53 and mut-p53 cancer cells. The studies have important implications for the investigation on anticancer effects of oroxylin A, and provide the academic basis for the clinical trial of oroxylin A in cancer patients.

P53 Sirna Inhibits Apoptosis of U2OS Cells Treated with Azurin.

[Selective Inducement Effect of Bacterial Redox Protein Azurin on Apoptosis of Human Osteosarcoma Cell Line U2OS].

Bacterial Redox Protein Azurin Induce Apoptosis in Human Osteosarcoma U2OS Cells.

[Cytotoxicity and apoptosis of human osteosarcoma U2OS cells induced by recombinant soluble AZURIN].

The Construction of the Eukaryotic Expression Plasmid Pcdna3.1/azurin and the Increased Apoptosis of U2OS Cells Transfected with It.

Activation of caspase- 3 during bacterial redox protein azurin -induced apoptosis in U2OS cells

Silencing of Mutant P53 by Sirna Induces Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

RNA Interference Targeting Mutant P53 Inhibits Growth and Induces Apoptosis in DU145 Human Prostate Cancer Cells

Modulation of bacterial redox protein azurin induces human osteosarcoma cell apoptosis by Fas antigen and caspase-8

The importance of copper in azurin molecular conformation and its apoptotic effect on oral cancer cell lines

Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis

Microrna-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.

Sb225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of P53 Status in Vitro

Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo

Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells

Arsenic Trioxide Induces Apoptosis in B-cell Chronic Lymphocytic Leukemic Cells Through Down-Regulation of Survivin Via the P53-Dependent Signaling Pathway

G1 Phase Cell Cycle Arrest in NSCLC in Response to LZ-106, an Analog of Enoxacin, is Orchestrated Through ROS Overproduction in a P53-dependent Manner

Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines

p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells

Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells